Not applicableUnknownNCT01089283
What this trial is testing
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80